Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

International "Comparability" Of Regulatory Standards May Be FDA's Solution To GMP Oversight

This article was originally published in PharmAsia News

Executive Summary

FDA may begin to rely on foreign government oversight of manufacturing even if the standards for the overseas regulators do not exactly match those in the U.S
Advertisement

Related Content

Mylan Grabs More FDA Globalization Talent
U.S. FDA Issues Warning Letters To Chinese Firms As Agency Tightens Foreign Field Inspections Program
Is Silence Golden For Brand Companies On Inspection Fees?
FDA Long-Term Globalization Strategy Under Development
U.S. FDA Head Says Chinese Heparin Contaminated On Purpose
Advertisement
UsernamePublicRestriction

Register

SC078488

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel